Mr. Lévesque, I commend you for telling us that story. It's important information for the public and the committee members to have. I think we want the same thing: reliable, sustainable access to drugs.
I told you the name of the task force the government set up to identify solutions. Can the group really find solutions when it has too few domestic manufacturers and generic drug makers? In fact, it doesn't have any. I haven't even told you who the patient and physician representatives are. That was just the manufacturers.
What do you think of that?